Federal Register / Vol. 79, No. 205 / Thursday, October 23, 2014 / Notices 63405 

project (a national surveillance system 

of such events). The objective of the 

project is to determine the annual 

number and temporal trends of SAEs 

associated with any treatment for LTBI 

in the United States. Surveillance of 

such events will provide data to support 

periodic evaluation or potential revision 

of guidelines for treatment of persons 

with LTBI. 

On December 9, 2011, CDC published 

the Recommendations for Use of an 

Isoniazid-Rifapentine Regimen with 

Direct Observation to Treat Latent 

Mycobacterium tuberculosis Infection in 

MMWR 2011;60(48);1650–1653. 

Isoniazid-Rifapentin (3HP) is a new 

biweekly 3-month treatment regimen for 

LTBI. Since 2011, there have been 28 

reports of SAE; 26 of these were 

associated with 3HP. 

The CDC requests approval for a 3- 

year extension of the previously 

approved National Surveillance for 

Severe Adverse Events Associated with 

Treatment of Latent Tuberculosis 

Infection. This project will continue the 

passive reporting system for SAEs 

associated with therapy for LTBI. The 

system will rely on medical chart 

review and/or onsite investigations by 

TB control staff. 

Potential respondents are any of the 

60 reporting areas for the national TB 

surveillance system (the 50 states, the 

District of Columbia, New York City, 

Puerto Rico, and 7 jurisdictions in the 

Pacific and Caribbean). 

Data will be collected using the data 

collection form for SAEs associated with 

LTBI treatment. Based on previous 

reporting, CDC anticipates receiving an 

average of 10 responses per year from 

the 60 reporting areas. The data 

collection form is completed by 

healthcare providers and health 

departments for each reported 

hospitalization or death related to 

treatment of LTBI and contains 

demographic, clinical, and laboratory 

information. 

CDC will analyze and periodically 

publish reports summarizing national 

LTBI treatment adverse events statistics 

and also will conduct special analyses 

for publication in peer-reviewed 

scientific journals to further describe 

and interpret these data. 

The Food and Drug Administration 

(FDA) collects data on adverse events 

related to drugs through the MedWatch: 

The FDA Medical Products Reporting 

Program (OMB#0910–0291, exp. 6/30/

2015). CDC is encouraging health 

departments and healthcare providers to 

report SAEs to FDA. Reporting will be 

conducted through telephone, email, or 

during CDC site visits. 

CDC is requesting approval for 

approximately 60 burden hours 

annually. The only cost to respondents 

is time to gather medical records and 

time to complete the reporting form. 

There are no costs to respondents other 

than their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of 

respondent Form name Number of respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Physician ......................................................... NSSAE ........................................................... 10 1 1 

Nurse ............................................................... NSSAE ........................................................... 10 1 4 

Medical Clerk .................................................. NSSAE ........................................................... 10 1 1 

Leroy A. Richardson, 

Chief, Information Collection Review Office, 

Office of Scientific Integrity, Office of the 

Associate Director for Science, Office of the 

Director, Centers for Disease Control and 

Prevention. 

[FR Doc. 2014–25250 Filed 10–22–14; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Intent To Award Ebola 

Response Outbreak Funding to African 

Field Epidemiology Network (AFENET) 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: This notice provides public 

announcement of CDC’s intent to award 

Ebola appropriations to AFENET for 

response to the Ebola outbreak funding. 

This award was proposed in Fiscal Year 

(FY) 2015 under funding opportunity 

announcement GH10–1006 

Strengthening the Development of 

Applied Epidemiology and Sustainable 

Public Health Capacity through 

Collaboration, Program Development 

and Implementation, Communication 

and Information Sharing.’’ 

Catalogue of Federal Domestic Assistance 

Number (CFDA): 93.283 

Authority: Public Health Service Act 42 

U.S.C. 287b 31 U.S.C. 6305 42 CFR 63a. 

Single award may be awarded totaling 

$1,800,000 for Ebola response outbreak. 

Funding is appropriated under the 

Continuing Appropriations Resolution, 

2015, Public Law 113–164, 128 Stat. 

1867 (2014). 

DATES: Anticipated award date 10/30/

2014 through 09/14/2015 

Application Due Date: 10/23/2014 

Project Number is CDC–RFA–GH10– 

1006 

ADDRESSES: CDC has waived the 

Grants.gov electronic submission 

process for this requirement. Recipients 

are hereby authorized to submit a paper 

copy application for (CDC–RFA–GH10– 

1006) via Express Mail (i.e. FedEx, UPS, 

or DHL) and send the application via 

email. Mailed applications must be 

address to Arthur C. Lusby, Centers for 

Disease Control and Prevention, 2920 

Brandywine Road, Atlanta, GA 30341, 

telephone (770) 488–2865, or email him 

at ALusby@cdc.gov. The application 

must include a detailed line-item budget 

and justification to support the Ebola 

activities from October 31, 2014 to 

September 29, 2015. Please download 

the following to complete the 

application package: http://

apply07.grants.gov/apply/forms/

sample/SF424_2_1-V2.1.pdf— 

Application Package; http://

www.cdc.gov/od/pgo/funding/docs/

CertificationsForm.pdf—Certifications; 

http://www.cdc.gov/od/pgo/funding/

grants/Budget_Preparation_Guidelines_

8-2-12.docx—CDC–PGO Budget 

Guidelines; http://apply07.grants.gov/

apply/forms/sample/SF424A-V1.0.pdf— 

SF–424A Budget Information. 

All applications must be submitted to 

and received by the Grants Management 

Officer (GMO) no later than 11:59 p.m. 

EST on October 23, 2014 and please 

provide the GMO a PDF version of the 

application by email to the following 

email address: pgoebolaresponse@

cdc.gov subject line: CDC–RFA–GH10– 

1006. 

mstockstill on DSK4VPTVN1PROD with NOTICES

63406 Federal Register / Vol. 79, No. 205 / Thursday, October 23, 2014 / Notices 

Applicants will be provided with the 

Funding Opportunity Announcement 

(FOA) and additional application 

submission guidance via email 

notification. Applicants may contact the 

POCs listed with questions regarding 

the application process. 

FOR FURTHER INFORMATION CONTACT: 

For Programmatic or Technical 

Assistance 

Kenneth Johnson, Project Officer, 

Department of Health and Human 

Services, Centers for Disease Control 

and Prevention, 1600 Clifton Rd MS E– 

93, Atlanta, GA 30333, Telephone: 404 

639–4203, KAJO@cdc.gov. 

For financial, awards management, or 

budget assistance: Arthur C. Lusby, 

Grants Management Officer, Centers for 

Disease Control and Prevention, 2920 

Brandywine Road, Atlanta, GA 30341, 

Telephone (770) 488–2865, Email: 

ALusby@cdc.gov. 

SUPPLEMENTARY INFORMATION: The 

purpose of this notice is to solicit an 

application from AFENET to assist in 

addressing the spread of the Ebola virus 

in West Africa and contain the disease 

as quickly as possible. The funding will 

support the impacted Ebola-affected 

countries and the surrounding countries 

to combat this health crisis. This 

funding will target the following 

countries: Liberia, Sierra Leone, Guinea, 

Burkina Faso, Niger, Mauritania, Mali, 

Senegal, Guinea Bissau, Ghana, Gambia, 

Cote d’Ivoire, Togo, Benin, and Nigeria 

to support the response to the outbreak 

of Ebola virus in West Africa. This 

funding will enable the U.S. to provide 

unified mobilization to address a crisis 

of this magnitude. CDC will continue to 

build partnerships and strengthen 

existing projects to respond to Ebola. 

CDC and its partners will help to 

address the need for surveillance, 

detection, coordination, response, and 

increase eligible governments’ capacity 

to respond to the Ebola outbreak. 

Award Information 

Type of Award: Expansion 

Supplement. 

Approximate Total Current Fiscal Year 

ACA Funding: $1,800,000. 

Anticipated Number of Awards: 

single. 

Fiscal Year Funds: 2015. 

Anticipated Award Date: October 30, 

2014. 

Application Selection Process: 

Funding will be awarded to applicant 

based on results from the technical 

review recommendation. 

Dated: October 20, 2014. 

Ron A. Otten, 

Acting Deputy Associate Director, Centers for 

Disease Control and Prevention. 

[FR Doc. 2014–25248 Filed 10–20–14; 4:15 pm] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Office of the Director; The Advisory 

Committee to the Director, CDC; 

Meeting 

Notice of Cancellation: This notice 

was published in the Federal Register 

on September 29, 2014, Volume 79, 

Number 189, page 58353. The meeting 

previously scheduled to convene on 

October 23, 2014 has been cancelled. 

Contact Person for More Information: 

Gayle Hickman, Committee 

Management Specialist, Office of the 

Chief of Staff, 1600 Clifton Road, Mail 

Stop D–14, Atlanta, GA 30303; 

telephone 404/639–7158, fax 404/639– 

7212; Email: ghickman@cdc.gov. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Claudette Grant, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. 2014–25258 Filed 10–22–14; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Board of Scientific Counselors, Office 

of Public Health Preparedness and 

Response, Board of Scientific 

Counselors (BSC, OPHPR); Notice of 

Meeting Cancellation 

Cancellation: This notice was 

published in the Federal Register on 

September 23, 2014, Volume 79, 

Number 184, page 56806. The meeting 

previously scheduled to convene on 

October 27–28, 2014, has been 

cancelled. 

Contact Person for More Information: 

Christye Brown, BSC Coordinator, 

Office of Science and Public Health 

Practice, Centers for Disease Control and 

Prevention, 1600 Clifton Road NE., 

Mailstop D–44, Atlanta, Georgia 30333, 

Telephone: (404) 639–7957; Facsimile: 

(404) 639–7977; Email: 

OPHPR.BSC.Questions@cdc.gov. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Claudette Grant, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. 2014–25163 Filed 10–22–14; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Child Support Enforcement Program; 

Report to Congress 

AGENCY: Administration for Children 

and Families, Department of Health and 

Human Services (HHS). 

ACTION: Notice of request for 

information. 

SUMMARY: The Department of Health and 

Human Services, Administration for 

Children and Families, Office of Child 

Support Enforcement requests public 

comments to inform its upcoming 

Report to Congress. The Report to 

Congress (‘‘Report’’) is required to be 

submitted no later than June 30, 2015 

under Title III, Section 305 of H.R. 4980 

(Pub. L. 113–183), Preventing Sex 

Trafficking and Strengthening Families 

Act of 2014. The legislation was signed 

into law on September 29, 2014. This 

Request for Information offers the 

opportunity for interested individuals 

and organizations to provide input on 

specific Report requirements or other 

information that would be valuable to 

the Report development. 

DATES: Comments must be received by 

11:59 p.m. on December 22, 2014, to be 

considered. 

ADDRESSES: Respondents are 

encouraged to submit their comments 

through the following methods; 

although email is the preferred method 

of submission. 

Email: Email comments concerning 

this notice to OCSEreport@acf.hhs.gov. 

Email submissions will receive an 

electronic confirmation acknowledging 

mstockstill on DSK4VPTVN1PROD with NOTICES